
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Li Duan, Kan Ouyang, Xiao Xu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 222
Li Duan, Kan Ouyang, Xiao Xu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 222
Showing 1-25 of 222 citing articles:
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Misganaw Asmamaw Mengstie, Belay Zawdie Wondimu
Biologics (2021) Vol. Volume 15, pp. 353-361
Open Access | Times Cited: 280
Misganaw Asmamaw Mengstie, Belay Zawdie Wondimu
Biologics (2021) Vol. Volume 15, pp. 353-361
Open Access | Times Cited: 280
Nanoparticles in Clinical Translation for Cancer Therapy
Deepa Mundekkad, William C. Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1685-1685
Open Access | Times Cited: 184
Deepa Mundekkad, William C. Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1685-1685
Open Access | Times Cited: 184
Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases
Tao Wan, Jiafeng Zhong, Qi Pan, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 173
Tao Wan, Jiafeng Zhong, Qi Pan, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 173
In vivo somatic cell base editing and prime editing
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
A long way to go: caspase inhibitors in clinical use
Shanel Dhani, Yun Zhao, Boris Zhivotovsky
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 118
Shanel Dhani, Yun Zhao, Boris Zhivotovsky
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 118
Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment
Yujie Liang, Xiao Xu, Limei Xu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4866-4878
Open Access | Times Cited: 117
Yujie Liang, Xiao Xu, Limei Xu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4866-4878
Open Access | Times Cited: 117
Nanotechnology, a frontier in agricultural science, a novel approach in abiotic stress management and convergence with new age medicine-A review
Safoora Mariyam, Sudhir K. Upadhyay, Koushik Chakraborty, et al.
The Science of The Total Environment (2023) Vol. 912, pp. 169097-169097
Closed Access | Times Cited: 79
Safoora Mariyam, Sudhir K. Upadhyay, Koushik Chakraborty, et al.
The Science of The Total Environment (2023) Vol. 912, pp. 169097-169097
Closed Access | Times Cited: 79
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models
Tuo Wei, Yehui Sun, Qiang Cheng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
Tuo Wei, Yehui Sun, Qiang Cheng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
Plant breeding advancements with “CRISPR-Cas” genome editing technologies will assist future food security
Muhammad Ahmad
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 58
Muhammad Ahmad
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 58
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification
Qisong Liu, Defeng Li, Xiaohua Pan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 56
Qisong Liu, Defeng Li, Xiaohua Pan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 56
Small Tech, Big Impact: Agri-nanotechnology Journey to Optimize Crop Protection and Production for Sustainable Agriculture
Abhishek Singh, Vishnu D. Rajput, Ashi Varshney, et al.
Plant Stress (2023) Vol. 10, pp. 100253-100253
Open Access | Times Cited: 51
Abhishek Singh, Vishnu D. Rajput, Ashi Varshney, et al.
Plant Stress (2023) Vol. 10, pp. 100253-100253
Open Access | Times Cited: 51
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
Frazer Sinclair, Anjuman Ara Begum, Charles C. Dai, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 5, pp. 1500-1519
Open Access | Times Cited: 45
Frazer Sinclair, Anjuman Ara Begum, Charles C. Dai, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 5, pp. 1500-1519
Open Access | Times Cited: 45
Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 39
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 39
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives
Farah Rehan, Mingjie Zhang, Jun Fang, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2073-2073
Open Access | Times Cited: 23
Farah Rehan, Mingjie Zhang, Jun Fang, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2073-2073
Open Access | Times Cited: 23
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
Li Duan, Kan Ouyang, Jianhong Wang, et al.
ChemBioChem (2021) Vol. 22, Iss. 24, pp. 3360-3368
Closed Access | Times Cited: 64
Li Duan, Kan Ouyang, Jianhong Wang, et al.
ChemBioChem (2021) Vol. 22, Iss. 24, pp. 3360-3368
Closed Access | Times Cited: 64
CRISPR Modeling and Correction of Cardiovascular Disease
Ning Liu, Eric N. Olson
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1827-1850
Open Access | Times Cited: 63
Ning Liu, Eric N. Olson
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1827-1850
Open Access | Times Cited: 63
Current Status and Challenges of Analytical Methods for Evaluation of Size and Surface Modification of Nanoparticle-Based Drug Formulations
Yuki Takechi‐Haraya, Takashi Ohgita, Yosuke Demizu, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 57
Yuki Takechi‐Haraya, Takashi Ohgita, Yosuke Demizu, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 57
Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications
Gargi Bhattacharjee, Nisarg Gohil, Khushal Khambhati, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 703-723
Closed Access | Times Cited: 53
Gargi Bhattacharjee, Nisarg Gohil, Khushal Khambhati, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 703-723
Closed Access | Times Cited: 53
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 38
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 38
Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ahmad Nazari, et al.
Environmental Research (2023) Vol. 239, pp. 117263-117263
Open Access | Times Cited: 35
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ahmad Nazari, et al.
Environmental Research (2023) Vol. 239, pp. 117263-117263
Open Access | Times Cited: 35
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 34
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 34
Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges
Jun Ueda, Taiga Yamazaki, Hiroshi Funakoshi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4778-4778
Open Access | Times Cited: 33
Jun Ueda, Taiga Yamazaki, Hiroshi Funakoshi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4778-4778
Open Access | Times Cited: 33
Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system
Apurwa Mishra, Rohit Kumar, Janhavi Mishra, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104694-104694
Closed Access | Times Cited: 31
Apurwa Mishra, Rohit Kumar, Janhavi Mishra, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104694-104694
Closed Access | Times Cited: 31